Sunshine Biopharma (SBFM) closes up to $20.4M public offering
Sunshine Biopharma announced the closing of an offering of up to $20.4 million.
Story updates
03:21:10 PM UTC
SquawkNews
$6.0 million upfront with an additional $14.4 million of potential aggregate gross proceeds upon the exercise of warrantsFORT LAUDERDALE, FL / / October 9, 2026 / Sunshine Biopharma Inc. NASDAQ:SBFM (the "Company"), a pharmaceutical company specializing in generic and specialty pres…
03:21:28 PM UTC
SquawkNews
Sunshine Biopharma closed a public offering for approximately $6.0M and issued Series D warrants that could add about $14.4M if fully exercised. Units priced at $0.55; warrants exercisable immediately at $0.66 and expire in five years.Material DetailsContext by AI AnalystThis is a financing step co…